ABC's Autism Outrage (from the New York Post)
By Jeff Stier, Esq.
Type : Editorial
Publish Date : Thursday, January 31, 2008
By Jeff Stier.  ABC tonight will include an extraordinary disclaimer on the first episode of its new series Eli Stone...  Read Full >>

The Science and Economics of Cholesterol Drugs (from MedicalProgressToday.com)
By Gilbert Ross, M.D.
Type : Articles
Publish Date : Friday, January 18, 2008
By Dr. Gilbert Ross.  The disappointing results of the ENHANCE drug trial have spurred a medical and media frenzy...  Read Full >>

The Supremacy of Preemption (from TCSDaily.com)
By Gilbert Ross, M.D.
Type : Editorial
Publish Date : Wednesday, January 9, 2008
By Dr. Gilbert Ross. Patients will benefit if the Supreme Court sides with pharmaceutical companies in two cases this session...  Read Full >>

Scary Year (from the Washington Times)
By Elizabeth M. Whelan, Sc.D., M.P.H.
Type : Editorial
Publish Date : Thursday, December 27, 2007
By Elizabeth M. Whelan. Does everything around us — food, air, water, consumer products — cause cancer or some other dread disease? You would think so, if you believed the cascade of health scares we witnessed during 2007.  Read Full >>

Evista for Chemoprevention of Breast Cancer: Better Late Than Never, FDA (from MedicalProgressToday.com)
By Gilbert Ross, M.D.
Publish Date : Friday, September 28, 2007
By Gilbert L. Ross.  An aphorism never truer: when discussing breast cancer, an ounce of prevention is better for public health than the cures currently available, and much cheaper. So, after a long–and–winding eight–year period of data accumulation, we should applaud the FDA for finally approving Lilly's "designer estrogen," Evista (raloxifene), for use in postmenopausal high–risk women to lower their risk of invasive breast cancer. But we should question why the FDA took this long in the first place...  Read Full >>